| scholarly article | Q13442814 |
| P50 | author | Guo-qing Zheng | Q42614367 |
| P2093 | author name string | Yan Wang | |
| Qun Zheng | |||
| Jia-Zhen Zhu | |||
| Xiao-Yi Bao | |||
| Ke-Jian Zhang | |||
| P2860 | cites work | The cardiovascular polypill: clinical data and ongoing studies | Q28072466 |
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| Pooling of animal experimental data reveals influence of study design and publication bias | Q30918723 | ||
| Vascular endothelial growth factor signaling in hypoxia and inflammation | Q33721685 | ||
| Catalpol Increases Brain Angiogenesis and Up-Regulates VEGF and EPO in the Rat after Permanent Middle Cerebral Artery Occlusion | Q34111415 | ||
| Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research | Q34595415 | ||
| Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells | Q35085094 | ||
| The efficacy of extraembryonic stem cells in improving blood flow within animal models of lower limb ischaemia. | Q35842843 | ||
| Angiogenesis: from plants to blood vessels | Q36477242 | ||
| Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature | Q36614453 | ||
| A systematic review and meta-analysis of buyang huanwu decoction in animal model of focal cerebral ischemia | Q36943081 | ||
| A review of neuroimaging studies of stressor-evoked blood pressure reactivity: emerging evidence for a brain-body pathway to coronary heart disease risk | Q37345037 | ||
| Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress | Q37345998 | ||
| How to read a review paper | Q37606619 | ||
| Dopamine agonists in animal models of Parkinson's disease: a systematic review and meta-analysis | Q37849963 | ||
| A guide to understanding meta-analysis | Q37897112 | ||
| GRADE guidelines: 5. Rating the quality of evidence--publication bias | Q37908618 | ||
| Evidence for the efficacy of statins in animal stroke models: a meta-analysis | Q38006716 | ||
| A network-based analysis of the types of coronary artery disease from traditional Chinese medicine perspective: potential for therapeutics and drug discovery | Q38165589 | ||
| Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges | Q38167295 | ||
| Coronary Collateral Growth Induced by Physical Exercise: Results of the Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease (EXCITE) Trial | Q38394779 | ||
| A Chinese patent medicine, Shexiang Baoxin Pill, for Non-ST-elevation acute coronary syndromes: A systematic review | Q39009615 | ||
| Cardiovascular science: opportunities for translating research into improved care | Q42438941 | ||
| Translating animal research into clinical benefit | Q42981287 | ||
| Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials. | Q43043733 | ||
| Concentration of vascular endothelial growth factor in patients with acute coronary syndrome | Q44194372 | ||
| The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease | Q46135770 | ||
| Forest plots. | Q51062465 | ||
| Pre-clinical systematic review | Q61413634 | ||
| Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs | Q71623264 | ||
| Translation of research evidence from animals to humans | Q79220569 | ||
| [Effect of fulu baoxin oral liquid on lipid peroxidation, plasma nitric oxide and vascular endothelial growth factor in acute myocardial infarction rats] | Q79376574 | ||
| Traditional Chinese medicine | Q79637865 | ||
| The serum metabolomic study of intervention effects of the traditional Chinese medicine Shexiang Baoxin Pill and a multi-component medicine polypill in the treatment of myocardial infarction in rats | Q84569309 | ||
| [Effect of medicines for activating blood and reinforcing Qi on angiogenesis in infarcted myocardium edge area of acute myocardial infarction model in rats] | Q85280161 | ||
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 404 | |
| P577 | publication date | 2017-06-28 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism | |
| P478 | volume | 8 |
| Q64887358 | Buyang Huanwu Decoction Exerts Cardioprotective Effects through Targeting Angiogenesis via Caveolin-1/VEGF Signaling Pathway in Mice with Acute Myocardial Infarction. |
| Q64986589 | Co-administration of Shexiang Baoxin Pill and Chemotherapy Drugs Potentiated Cancer Therapy by Vascular-Promoting Strategy. |
| Q60960115 | Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool |
| Q98289696 | Effect of herbs for treating coronary heart disease on the CYP450 enzyme system and transporters |
| Q90092515 | Efficacy of Shexiang Baoxin Pills for the treatment of unstable angina pectoris: Protocol of systemic review and meta-analysis |
| Q61812519 | Fucoidan⁻Fucoxanthin Ameliorated Cardiac Function via IRS1/GRB2/ SOS1, GSK3β/CREB Pathways and Metabolic Pathways in Senescent Mice |
| Q51244988 | Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria. |
| Q59328977 | Shexiang Baoxin Pill, Derived From the Traditional Chinese Medicine, Provides Protective Roles Against Cardiovascular Diseases |
| Q55088794 | Shexiang Baoxin Pills as an Adjuvant Treatment for Chronic Heart Failure: A System Review and Meta-Analysis. |
Search more.